GSK plc Estimated Financial Effect Of Contingent Liabilities
GSK plc (GLAXF) had Estimated Financial Effect Of Contingent Liabilities of GBP 38.00 million as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:EstimatedFinancialEffectOfContingentLiabilities · last filed 2026-03-06
- 2025-12-31: Estimated Financial Effect Of Contingent Liabilities 38.00M GBP.
- 2024-12-31: Estimated Financial Effect Of Contingent Liabilities 26.00M GBP.
- 2023-12-31: Estimated Financial Effect Of Contingent Liabilities 32.00M GBP.
- 2022-12-31: Estimated Financial Effect Of Contingent Liabilities 58.00M GBP.
| Period end | Estimated Financial Effect Of Contingent Liabilities |
|---|---|
| 2025-12-31 | 38.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 26.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 32.00M GBP 20-F · filed 2025-03-03 |
| 2022-12-31 | 58.00M GBP 20-F · filed 2024-03-05 |
| 2021-12-31 | 126.00M GBP 20-F · filed 2023-03-10 |
| 2020-12-31 | 138.00M GBP 20-F · filed 2022-03-08 |
| 2019-12-31 | 97.00M GBP 20-F · filed 2021-03-12 |
| 2018-12-31 | 93.00M GBP 20-F · filed 2020-03-06 |
| 2017-12-31 | 434.00M GBP 20-F · filed 2019-03-15 |
| 2016-12-31 | 281.00M GBP 20-F/A · filed 2018-03-20 |